Digital healthcare technology company Indegene is expanding its global operations and building an acquisition pipeline to support future growth. Earlier this year, the company acquired US-based BioPharm Communications from Omnicom Health Group in an all-cash transaction valued at about USD 106 million, subject to adjustments. The acquisition strengthens Indegene’s marketing and AdTech capabilities in the United States, which remains its largest market.

Manish Gupta, Chairman and Chief Executive Officer (CEO) of Indegene, said the company continues to prioritise organic growth while evaluating opportunities that align with its core business. “If we find companies that complement and augment our capabilities, we go ahead and acquire them,” he said. “We remain a disciplined acquirer, guided

See Full Page